Efficacy and pharmacokinetic activity of frovatriptan compared to rizatriptan in patients with moderate-to-severe migraine

References

• Lipton RB Chronic migraine, classification, differential diagnosis, and epidemiology Headache 2011 51 Suppl 2 77 83 21770929
   PubMed Web of Science ®Google Scholar
• Headache Classification Subcommittee of the International Headache Society The International Classification of Headache Disorders 2nd ed Cephalalgia 2004 24 Suppl 1 9 160 14979299
   PubMed Web of Science ®Google Scholar
• Bellini B Arruda M Cescut A Headache and comorbidity in children and adolescents J Headache Pain 2013 14 79 24063537
   PubMed Web of Science ®Google Scholar
• Jacobs H Gladstein J Pediatric headache: a clinical review Headache 2012 52 2 333 339 22288433
   PubMed Web of Science ®Google Scholar
• Silberstein SD Holland S Freitag F Dodick DW Argoff C Ashman E Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society Neurology 2012 78 17 1337 1345 22529202
   PubMed Web of Science ®Google Scholar
• Loder E Triptan therapy in migraine N Engl J Med 2010 363 1 63 70 20592298
   PubMed Web of Science ®Google Scholar
• Cady R Schreiber C Sumatriptan: update and review Expert Opin Pharmacother 2006 7 11 1503 1514 16859433
   PubMed Web of Science ®Google Scholar
• Tfelt-Hansen P De Vries P Saxena PR Triptans in migraine: a comparative review of pharmacology, pharmacokinetics and efficacy Drugs 2000 60 6 1259 1287 11152011
   PubMed Web of Science ®Google Scholar
• Balbisi EA Frovatriptan succinate, a 5-HT1B/1D receptor agonist for migraine Int J Clin Pract 2004 58 7 695 705 15311727
   PubMed Web of Science ®Google Scholar
• Kelman L Review of frovatriptan in the treatment of migraine Neuropsychiatr Dis Treat 2008 4 1 49 54 18728819
   PubMedGoogle Scholar
• Sanford M Frovatriptan: a review of its use in the acute treatment of migraine CNS Drugs 2012 26 9 791 811 22900951
   PubMed Web of Science ®Google Scholar
• Comer MB Pharmacology of the selective 5-HT(1B/1D) agonist frovatriptan Headache 2002 42 Suppl 2 S47 S53 12028320
   PubMed Web of Science ®Google Scholar
• Buchan P Keywood C Wade A Ward C Clinical pharmacokinetics of frovatriptan Headache 2002 42 Suppl 2 S54 S62 12028321
   PubMed Web of Science ®Google Scholar
• Buchan P Wade A Ward C Oliver SD Stewart AJ Freestone S Frovatriptan: a review of drug-drug interactions Headache 2002 42 Suppl 2 S63 S73 12028322
   PubMed Web of Science ®Google Scholar
• Goldberg MR Lee Y Vyas KP Rizatriptan, a novel 5-HT1B/1D agonist for migraine: single- and multiple-dose tolerability and pharmacokinetics in healthy subjects J Clin Pharmacol 2000 40 1 74 83 10631625
   PubMed Web of Science ®Google Scholar
• Mannix LK A review of the 5-HT1B/1D agonist rizatriptan: update on recent research and implications for the future Expert Opin Pharmacother 2008 9 6 1001 1011 18377342
   PubMed Web of Science ®Google Scholar
• Ferrari MD Goadsby PJ Roon KI Lipton RB Triptans (serotonin, 5-HT1B/1D agonists) in migraine: detailed results and methods of a meta-analysis of 53 trials Cephalalgia 2002 22 8 633 658 12383060
   PubMed Web of Science ®Google Scholar
• Vyas KP Halpin RA Geer LA Disposition and pharmacokinetics of the antimigraine drug, rizatriptan, in humans Drug Metab Dispos 2000 28 1 89 95 10611145
   PubMed Web of Science ®Google Scholar
• Savi L Omboni S Lisotto C Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan J Headache Pain 2011 12 6 609 615 21842274
   PubMed Web of Science ®Google Scholar
• Savi L Omboni S Lisotto C A double-blind, randomized, multicenter, Italian study of frovatriptan versus rizatriptan for the acute treatment of migraine J Headache Pain 2011 12 2 219 226 20686810
   PubMed Web of Science ®Google Scholar
• Lipton RB Goadsby PJ Sawyer JP Blakeborough P Stewart WF Migraine: diagnosis and assessment of disability Rev Contemp Pharmacother 2000 11 2 63 73
   Web of Science ®Google Scholar
• Géraud G Keywood C Senard JM Migraine headache recurrence: relationship to clinical, pharmacological, and pharmacokinetic properties of triptans Headache 2003 43 4 376 388 12656709
   PubMed Web of Science ®Google Scholar
• Bartolini M Giamberardino MA Lisotto C A double-blind, randomized, multicenter, Italian study of frovatriptan versus almotriptan for the acute treatment of migraine J Headache Pain 2011 12 3 361 368 21437714
   PubMed Web of Science ®Google Scholar
• Tullo V Allais G Curone M Frovatriptan versus zolmitriptan for the acute treatment of migraine with aura: a subgroup analysis of a double-blind, randomized, multicenter, Italian study Neurol Sci 2012 33 Suppl 1 S61 S64 22644173
   PubMed Web of Science ®Google Scholar
• Elkind AH Wade A Ishkanian G Pharmacokinetics of frovatriptan in adolescent migraineurs J Clin Pharmacol 2004 44 10 1158 1165 15342617
   PubMed Web of Science ®Google Scholar
• Goldstein J Frovatriptan: a review Expert Opin Pharmacother 2003 4 1 83 93 12517245
   PubMed Web of Science ®Google Scholar
• Ferrari A Tiraferri I Neri L Sternieri E Why pharmacokinetic differences among oral triptans have little clinical importance: a comment J Headache Pain 2011 12 1 5 12 20878535
   PubMed Web of Science ®Google Scholar
• Electronic Medicines Compendium Migard (frovatriptan succinate monohydrate) [summary of product characteristics] Available from: http://www.medicines.org.uk/emc/medicine/15211/XPIL/Migard Accessed October 29, 2013
   Google Scholar
• Endo Pharmaceuticals Frova (frovatriptan succinate tablets) [prescribing information] Dublin Endo Pharmaceuticals 2013 Available from: http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/021006s019lbl.pdf Accessed October 29, 2013
   Google Scholar